Searchable abstracts of presentations at key conferences on calcified tissues

ba0007p215 | (1) | ICCBH2019

Evaluating the natural history of subcutaneous fat necrosis

Lautatzis Maria-Elena , Harrington Jennifer

Background: Subcutaneous fat necrosis (SCFN) of the newborn is an uncommon condition most commonly seen in term infants who have experienced perinatal stress presenting as nodules or plaques on the face, back or upper extremities. The associated complication of hypercalcemia is thought to be secondary to elevated 1,25-OH vitamin D from increased expression of 1-alpha hydroxylase from inflammatory granulomatous cells. However the natural history of SCFN, associated hypercalcemi...

ba0001pp150 | Cancer and bone: basic, translational and clinical | ECTS2013

Inhibition of osteoclastogenesis by proton pump inhibitors on co-cultures of human osteoclasts and breast cancer cells

Reis Sara , Fernandes Maria , Costa-Rodrigues Joao

Proton pump inhibitors (PPIs) are a class of drugs particularly used in gastric disorders. They promote a decrease on gastric acid secretion by inhibiting the H+/K+ ATPases. Osteoclasts are cells specialized in bone resorption by H+ translocation to the bone surface. Thus, PPIs might be regarded as potential tools to modulate osteoclast resorption activity, particularly in conditions that are associated with a hyperactivation of osteoclasts, li...

ba0001pp220 | Cell biology: osteoclasts and bone resorption | ECTS2013

Modulation of osteoclastogenesis by fluoroquinolones on nano- and micro-structurated hydroxyapatite surfaces

Ribeiro Sofia , Costa-Rodrigues Joao , Fernandes Maria

Hydroxyapatite (HA) has been widely used as a biocompatible ceramic in many areas of medicine, mainly for contact with bone tissue, due to its resemblance to mineral bone. Owing to the nanofeatures of bone tissue, new nano-HA based materials are among the most promising challenges in bioactive ceramics. Recently, it was observed that fluoroquinolones have the ability to interfere with osteoclastogenesis, in standard polystyrene cell culture plates. The aim of this work is to a...

ba0001pp489 | Other diseases of bone and mineral metabolism | ECTS2013

Homeostasis of calcium and vitamin D in patients with aggressive periodontitis

Zyablitskaya Maria , Atrushkevich Victoria , Mkrtumian Ashot

Aim: Periodontologists all over the world are more and more interested in connection between pathogenesis of aggressive periodontitis (AP) and calcium and vitamin D metabolic disturbances. Vitamin D besides its direct effect on calcium homeostasis, has immunomodulatory action, that makes interesting the study of vitamin D effect on pathogenesis of AP.Materials and methods: We studied 102 (49 males; 53 females) patients with AP (40.32±1.13), 42 patie...

ba0002op2 | (1) | ICCBH2013

High FSH serum levels may support the altered bone remodeling in Turner syndrome patients

Brunetti Giacomina , Ventura Anna Maria , Piacente Laura , Oranger Angela , Ciccarelli Maria , Mori Giorgio , Colucci Silvia , Cavallo Luciano , Grano Maria , Faienza Maria Felicia

Objective: Turner syndrome (TS) is a chromosomal aberration characterized by total or partial loss of one of the two X-chromosomes, and affects about 1 in every 2500 girls. TS patients can develop the bone disease with decreased bone density and selective reduction in cortical bone thickness, which probably contributes to the increased fracture risk. However, the mechanisms underlying the bone disease remain poorly understood. Thus, the aim of this study was to investigate the...

ba0002p76 | (1) | ICCBH2013

Final height and bone health in young adults, transplanted in childhood

Dyck Maria Van , Herman Jean , Lombaerts Rita

: This study analyses the long-term effect of rhGH on final height (FH) and bone health in renal transplanted patients.Twenty-one young adult patients, aged 17–26 years, were studied. Group A consisted of 15 patients (12 boys) who received rhGH during 3.0 years before transplantation. After transplantation three boys needed rhGH again for 3.5 years. In group B six patients (three boys) didn’t need rhGH before transplantation, three girls receiv...

ba0003pp342 | Osteoporosis: treatment | ECTS2014

Assessment treatment with denosumab in clinical practice

Torrea Maria , Carretero Lorena , Filgueira Jose Santiago

Introduction: Denosumab monoclonal antibody approved for Osteoporosis’s treatment in Europe union and U.S.A. Dose of 60 mg every 6 months reduces the risk of vertebral, non vertebral and hip fractures. What is more increases BMDMaterial and methods: Descriptive observational study with densitometric characterisques and risk factors of 64 patients in Osteoporosis unit of HGUG Marañón from November 2011 to December 2013. Analyzing occurrence...

ba0001pp365 | Osteoporosis: pathophysiology and epidemiology | ECTS2013

Effect of sitagliptin on bone growth and remodeling in non-ovariectomized and ovariectomized rats

Pytlik Maria , Folwarczna Joanna , Fronczek-Sokol Justyna , Smyla Adam , Wiecek Patrycja , Zych Maria

Type 2 diabetes and osteoporosis often occur together in postmenopausal women. Sitagliptin is a new drug used in the therapy of type 2 diabetes; it affects incretin system as a result of inhibition of dipeptidyl peptidase-4. So far, the impact of the drug on bone remodeling processes is unknown. The aim of this study was to investigate the effect of sitagliptin on bone growth and remodeling in non-ovariectomized and ovariectomized rats.The experiments we...

ba0001pp366 | Osteoporosis: pathophysiology and epidemiology | ECTS2013

Caffeine at a moderate dose favorably affected bone mechanical properties in ovariectomized rats

Folwarczna Joanna , Pytlik Maria , Zych Maria , Cegiela Urszula , Kaczmarczyk-Sedlak Ilona , Nowinska Barbara , Sliwinski Leszek

Caffeine, a methylxanthine present in coffee, tea, coca-cola and other beverages, is considered to be responsible for an increased risk of osteoporosis in coffee drinkers, however the data from human and experimental studies are inconsistent. The aim of this study was to investigate the effects of a moderate dose of caffeine on the skeletal system of rats with normal and decreased estrogen level (developing osteoporosis due to estrogen deficiency).Caffei...

ba0002oc13 | Diagnostics | ICCBH2013

Level of calcium intake modifies the correlation between parathyroid hormone and 25-hydroxyvitamin D: a proposal of adequate 25-hydroxyvitamin D levels in children

Reyes Maria Loreto , Molina Marcela , Escobar Raul , Hernandez Maria Isabel , Cavada Gabriel , Jr Camargo Carlos Arturo

Background: The ‘adequate’ level of 25-hydroxyvitamin D (25OHD) in children remains unclear. For bone outcomes, parathyroid hormone (PTH) is an important functional biomarker. Prior studies have shown too weak a correlation between 25OHD and PTH levels to determine adequate 25OHD level.Objective: To determine adequate 25OHD level(s) in children using a normal PTH value of 65 pg/ml while adjusting for calcium intake.Design...